Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort

Aim: The aim of this study was to investigate the incidence and characteristics of c-Cbl mutations in acute myeloid leukaemias (AMLs) from an Australian patient cohort. Two initial studies examining c-Cbl mutations in AML, one from Germany and one from the US, found vastly different incidences of mu...

Full description

Bibliographic Details
Main Authors: Ghassemifar, Reza, Thien, C., Finlayson, J., Joske, D., Cull, G., Augustson, B., Langdon, W.
Format: Journal Article
Published: 2011
Online Access:http://hdl.handle.net/20.500.11937/37066
_version_ 1848754944784465920
author Ghassemifar, Reza
Thien, C.
Finlayson, J.
Joske, D.
Cull, G.
Augustson, B.
Langdon, W.
author_facet Ghassemifar, Reza
Thien, C.
Finlayson, J.
Joske, D.
Cull, G.
Augustson, B.
Langdon, W.
author_sort Ghassemifar, Reza
building Curtin Institutional Repository
collection Online Access
description Aim: The aim of this study was to investigate the incidence and characteristics of c-Cbl mutations in acute myeloid leukaemias (AMLs) from an Australian patient cohort. Two initial studies examining c-Cbl mutations in AML, one from Germany and one from the US, found vastly different incidences of mutations (0.6% compared to 33%, respectively). Therefore, it was important to determine the incidence and characteristics of c-Cbl mutations in a cohort of Australian AML patients. Methods: Ninety patients with AML were investigated. The open reading frame between exons 4 and 11 of the c-Cbl gene was analysed by reverse-transcription polymerase chain reaction (RT-PCR), nested PCR and DNA sequencing. Results: We found four AML samples (4/90; 4.44%) with distinct c-Cbl deletions involving exons 6 to 9. Sample 10 [AML with t(8;21)] showed two deletions [c.870-1007del] and [c.1106-1228del]. Sample 81 (AML with minimal differentiation) showed a large deletion [c.1008-1431del] causing a frameshift and a premature stop codon. Sample 82 (AML without maturation) showed two deletions [c.928- 1307del] and [c.1385-1431del] also causing a frameshift and a premature stop codon. Sample 84 (AML with myelodysplasia related changes) showed a large deletion [c.964-1380del]. Conclusion: Although our data indicate that c-Cbl deletions are not common in AML in the Australian population, they do raise the possibility that c-Cbl mutations might contribute to the pathogenesis of these AML cases. © 2011 Royal College of Pathologists of Australasia.
first_indexed 2025-11-14T08:48:28Z
format Journal Article
id curtin-20.500.11937-37066
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:48:28Z
publishDate 2011
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-370662017-09-13T15:24:21Z Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort Ghassemifar, Reza Thien, C. Finlayson, J. Joske, D. Cull, G. Augustson, B. Langdon, W. Aim: The aim of this study was to investigate the incidence and characteristics of c-Cbl mutations in acute myeloid leukaemias (AMLs) from an Australian patient cohort. Two initial studies examining c-Cbl mutations in AML, one from Germany and one from the US, found vastly different incidences of mutations (0.6% compared to 33%, respectively). Therefore, it was important to determine the incidence and characteristics of c-Cbl mutations in a cohort of Australian AML patients. Methods: Ninety patients with AML were investigated. The open reading frame between exons 4 and 11 of the c-Cbl gene was analysed by reverse-transcription polymerase chain reaction (RT-PCR), nested PCR and DNA sequencing. Results: We found four AML samples (4/90; 4.44%) with distinct c-Cbl deletions involving exons 6 to 9. Sample 10 [AML with t(8;21)] showed two deletions [c.870-1007del] and [c.1106-1228del]. Sample 81 (AML with minimal differentiation) showed a large deletion [c.1008-1431del] causing a frameshift and a premature stop codon. Sample 82 (AML without maturation) showed two deletions [c.928- 1307del] and [c.1385-1431del] also causing a frameshift and a premature stop codon. Sample 84 (AML with myelodysplasia related changes) showed a large deletion [c.964-1380del]. Conclusion: Although our data indicate that c-Cbl deletions are not common in AML in the Australian population, they do raise the possibility that c-Cbl mutations might contribute to the pathogenesis of these AML cases. © 2011 Royal College of Pathologists of Australasia. 2011 Journal Article http://hdl.handle.net/20.500.11937/37066 10.1097/PAT.0b013e328343ca4b restricted
spellingShingle Ghassemifar, Reza
Thien, C.
Finlayson, J.
Joske, D.
Cull, G.
Augustson, B.
Langdon, W.
Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
title Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
title_full Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
title_fullStr Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
title_full_unstemmed Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
title_short Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
title_sort incidence of c-cbl mutations in human acute myeloid leukaemias in an australian patient cohort
url http://hdl.handle.net/20.500.11937/37066